Tuberculosis Screening

Tuberculosis screening looks for your immune response to TB germs or signs of infection that need further assessment.

Screening can help identify latent tuberculosis infection, where TB germs are present but a person has no symptoms and cannot pass TB to others. It can also be part of the assessment when active tuberculosis is a concern. A test result is interpreted alongside your health history, symptoms, examination, and sometimes imaging.

A clinician may offer a blood test called an IGRA, which needs a blood sample from a vein. Another option is the Mantoux skin test: a small amount of testing fluid is placed just beneath the skin of the forearm, then the site is checked at a return visit. Do not scratch or cover the skin-test area unless your clinician gives specific instructions.

Both methods are commonly used and usually cause only brief discomfort from a needle. Blood testing avoids a return visit for skin reading. No screening test alone confirms whether TB is active, whether infection happened recently, or whether symptoms have another cause. Previous vaccination, immune-suppressing medicines, and a very recent exposure can affect which test is suitable or how a result is interpreted.

A positive or unclear result prompts a clinician to check for symptoms and consider further testing. This may include a chest X-ray or samples for laboratory testing when active illness needs to be excluded. If active disease is not found, the conversation may turn to treatment for latent tuberculosis infection. A positive screening result does not by itself show that you have active TB or that you are infectious.

Tell the clinician about TB exposure, prior TB treatment, BCG vaccination, pregnancy, immune conditions, and medicines that suppress immunity. Bring details of any earlier TB test if you have them. Screening is particularly useful when the result will guide a health, work, travel, or treatment decision.

Screening may be considered after close contact with someone with infectious TB, before medicines that weaken immune responses, or when a workplace or education setting requires it. Clinicians also consider personal exposure history, including time spent in places where TB is more common. The choice of test is individual rather than routine for everyone.

The clinician first asks about exposure, symptoms, and previous results. For a blood test, the sample is taken and you can usually leave straight away. For a skin test, keep the return appointment so the clinician can assess the reaction. Contact the clinic if you cannot return as arranged, because the test may need to be repeated.

There is no recovery period after either screening method. The puncture site can be mildly sore or bruised for a short time. Your clinician will explain when and how results will be communicated, and whether an in-person review is needed.

Minor soreness, a small bruise, or local skin irritation can occur. Seek urgent medical advice for trouble breathing, widespread hives, fainting that does not settle, or rapidly worsening swelling after any injection or blood draw. If you have cough, fever, night sweats, unexplained weight loss, or are feeling increasingly unwell, seek a prompt clinical assessment rather than relying on screening alone.

A chest X-ray can show changes in the lungs but does not replace immune-response testing for every purpose. Symptom review, examination, and laboratory samples may be more appropriate when active tuberculosis is suspected. Your clinician can explain which combination answers the question in your situation.

Choose a clinic that can arrange the test, interpret it in the context of your medical history, and coordinate follow-up if needed. Before booking, ask whether the service offers the recommended test and how results are shared.